Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,982
archived clinical trials in
Endocrine

A Novel Diet-Phenotype Interaction Affecting Body Weight
A Novel Diet-Phenotype Interaction Affecting Body Weight
Status: Enrolling
Updated:  2/8/2016
University of North Carolina at Chapel Hill
2189
mi
from 91732
Chapel Hill, NC
A Novel Diet-Phenotype Interaction Affecting Body Weight
A Novel Diet-Phenotype Interaction Affecting Body Weight
Status: Enrolling
Updated: 2/8/2016
University of North Carolina at Chapel Hill
2189
mi
from 91732
Chapel Hill, NC
Click here to add this to my saved trials
A Novel Diet-Phenotype Interaction Affecting Body Weight
A Novel Diet-Phenotype Interaction Affecting Body Weight
Status: Enrolling
Updated:  2/8/2016
Children's Hospital Boston
2576
mi
from 91732
Boston, MA
A Novel Diet-Phenotype Interaction Affecting Body Weight
A Novel Diet-Phenotype Interaction Affecting Body Weight
Status: Enrolling
Updated: 2/8/2016
Children's Hospital Boston
2576
mi
from 91732
Boston, MA
Click here to add this to my saved trials
One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study
Determining the Maximal Safe Dose of a Continuous Infusion of Parathyroid Hormone-related Protein(1-36): Effects on Bone Formation
Status: Enrolling
Updated:  2/9/2016
University of Pittsburgh Medical Center
2121
mi
from 91732
Pittsburgh, PA
One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study
Determining the Maximal Safe Dose of a Continuous Infusion of Parathyroid Hormone-related Protein(1-36): Effects on Bone Formation
Status: Enrolling
Updated: 2/9/2016
University of Pittsburgh Medical Center
2121
mi
from 91732
Pittsburgh, PA
Click here to add this to my saved trials
Twenty-four Hour Intraocular Pressure Patterns in Patients With Uncontrolled Thyroid Eye Disease
The Effects of Orbital Decompression Surgery on Intraocular Pressure Patterns in Patient With Thyroid Eye Disease Undergoing 24 Hour Continuous IOP Monitoring With the SENSIMED Triggerfish®
Status: Enrolling
Updated:  2/15/2016
Shiley Eye Center, University of California, San Diego
94
mi
from 91732
La Jolla, CA
Twenty-four Hour Intraocular Pressure Patterns in Patients With Uncontrolled Thyroid Eye Disease
The Effects of Orbital Decompression Surgery on Intraocular Pressure Patterns in Patient With Thyroid Eye Disease Undergoing 24 Hour Continuous IOP Monitoring With the SENSIMED Triggerfish®
Status: Enrolling
Updated: 2/15/2016
Shiley Eye Center, University of California, San Diego
94
mi
from 91732
La Jolla, CA
Click here to add this to my saved trials
Effect of Naltrexone on Counterregulatory Mechanisms in Hypoglycemia
The Effect of Opiate Blockade With Naltrexone on Counterregulatory Mechanisms in Hypoglycemia
Status: Enrolling
Updated:  2/17/2016
Yale School of Medicine
2486
mi
from 91732
New Haven, CT
Effect of Naltrexone on Counterregulatory Mechanisms in Hypoglycemia
The Effect of Opiate Blockade With Naltrexone on Counterregulatory Mechanisms in Hypoglycemia
Status: Enrolling
Updated: 2/17/2016
Yale School of Medicine
2486
mi
from 91732
New Haven, CT
Click here to add this to my saved trials
Effect of Age on Glucose and Lipid Metabolism
Effect of Age on Glucose and Lipid Metabolism
Status: Enrolling
Updated:  2/17/2016
Texas Diabetes Insitute
1187
mi
from 91732
San Antonio, TX
Effect of Age on Glucose and Lipid Metabolism
Effect of Age on Glucose and Lipid Metabolism
Status: Enrolling
Updated: 2/17/2016
Texas Diabetes Insitute
1187
mi
from 91732
San Antonio, TX
Click here to add this to my saved trials
Comparison of Endobronchial Ultrasound-Guided Biopsy Using Fine Needle Aspiration Versus Fine Needle Capillary Sampling
Specimen Adequacy and Diagnostic Agreement of Fine Needle Aspiration (FNA) VS. Fine Needle Capillary Sampling (FNC) of Endobronchial Ultrasound-Guided Biopsy of Mediastinal Lymph Nodes
Status: Enrolling
Updated:  2/17/2016
UT MD Anderson Cancer Center
1357
mi
from 91732
Houston, TX
Comparison of Endobronchial Ultrasound-Guided Biopsy Using Fine Needle Aspiration Versus Fine Needle Capillary Sampling
Specimen Adequacy and Diagnostic Agreement of Fine Needle Aspiration (FNA) VS. Fine Needle Capillary Sampling (FNC) of Endobronchial Ultrasound-Guided Biopsy of Mediastinal Lymph Nodes
Status: Enrolling
Updated: 2/17/2016
UT MD Anderson Cancer Center
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Trial of LBH589 in Metastatic Thyroid Cancer
A Phase II Trial of LBH589 in Patients With Metastatic Medullary Thyroid Cancer and Radioactive Iodine Resistant Differentiated Thyroid Cancer
Status: Enrolling
Updated:  2/18/2016
St Vincent Regional Cancer Center CCOP
1745
mi
from 91732
Green Bay, WI
Trial of LBH589 in Metastatic Thyroid Cancer
A Phase II Trial of LBH589 in Patients With Metastatic Medullary Thyroid Cancer and Radioactive Iodine Resistant Differentiated Thyroid Cancer
Status: Enrolling
Updated: 2/18/2016
St Vincent Regional Cancer Center CCOP
1745
mi
from 91732
Green Bay, WI
Click here to add this to my saved trials
Trial of LBH589 in Metastatic Thyroid Cancer
A Phase II Trial of LBH589 in Patients With Metastatic Medullary Thyroid Cancer and Radioactive Iodine Resistant Differentiated Thyroid Cancer
Status: Enrolling
Updated:  2/18/2016
University of Wisconsin-Madison
1654
mi
from 91732
Madison, WI
Trial of LBH589 in Metastatic Thyroid Cancer
A Phase II Trial of LBH589 in Patients With Metastatic Medullary Thyroid Cancer and Radioactive Iodine Resistant Differentiated Thyroid Cancer
Status: Enrolling
Updated: 2/18/2016
University of Wisconsin-Madison
1654
mi
from 91732
Madison, WI
Click here to add this to my saved trials
Trial of LBH589 in Metastatic Thyroid Cancer
A Phase II Trial of LBH589 in Patients With Metastatic Medullary Thyroid Cancer and Radioactive Iodine Resistant Differentiated Thyroid Cancer
Status: Enrolling
Updated:  2/18/2016
Medical College of Wisconsin
1729
mi
from 91732
Milwaukee, WI
Trial of LBH589 in Metastatic Thyroid Cancer
A Phase II Trial of LBH589 in Patients With Metastatic Medullary Thyroid Cancer and Radioactive Iodine Resistant Differentiated Thyroid Cancer
Status: Enrolling
Updated: 2/18/2016
Medical College of Wisconsin
1729
mi
from 91732
Milwaukee, WI
Click here to add this to my saved trials
Ponatinib for Advanced Medullary Thyroid Cancer
A Phase II Study of Ponatinib in Advanced or Metastatic Medullary Thyroid Cancer
Status: Enrolling
Updated:  2/18/2016
National Institutes of Health Clinical Center, 9000 Rockville Pike
2277
mi
from 91732
Bethesda, MD
Ponatinib for Advanced Medullary Thyroid Cancer
A Phase II Study of Ponatinib in Advanced or Metastatic Medullary Thyroid Cancer
Status: Enrolling
Updated: 2/18/2016
National Institutes of Health Clinical Center, 9000 Rockville Pike
2277
mi
from 91732
Bethesda, MD
Click here to add this to my saved trials
Metabolic Effects of Androgenicity in Aging Men and Women
Metabolic Effects of Androgenicity in Aging Men and Women
Status: Enrolling
Updated:  2/19/2016
VA Greater Los Angeles Healthcare System, West LA
25
mi
from 91732
West Los Angeles, CA
Metabolic Effects of Androgenicity in Aging Men and Women
Metabolic Effects of Androgenicity in Aging Men and Women
Status: Enrolling
Updated: 2/19/2016
VA Greater Los Angeles Healthcare System, West LA
25
mi
from 91732
West Los Angeles, CA
Click here to add this to my saved trials
Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia
Diet/Exercise, Niacin, Fenofibrate for HIV Lipodystrophy
Status: Enrolling
Updated:  2/25/2016
Baylor College of Medicine
1357
mi
from 91732
Houston, TX
Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia
Diet/Exercise, Niacin, Fenofibrate for HIV Lipodystrophy
Status: Enrolling
Updated: 2/25/2016
Baylor College of Medicine
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia in Type 1 Diabetes.
The Effect of the Beta 2 Agonist, Formoterol, on Recovery From Hypoglycemia
Status: Enrolling
Updated:  2/26/2016
Yale University School of Medicine
2486
mi
from 91732
New Haven, CT
Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia in Type 1 Diabetes.
The Effect of the Beta 2 Agonist, Formoterol, on Recovery From Hypoglycemia
Status: Enrolling
Updated: 2/26/2016
Yale University School of Medicine
2486
mi
from 91732
New Haven, CT
Click here to add this to my saved trials
Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal Hyperplasia
A Phase 2, Open Label, Crossover Pharmacokinetic and Pharmacodynamic Study to Compare Chronocort Versus Cortef in Patients With CAH
Status: Enrolling
Updated:  2/26/2016
National Institutes of Health Clinical Center, 9000 Rockville Pike
2277
mi
from 91732
Bethesda, MD
Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal Hyperplasia
A Phase 2, Open Label, Crossover Pharmacokinetic and Pharmacodynamic Study to Compare Chronocort Versus Cortef in Patients With CAH
Status: Enrolling
Updated: 2/26/2016
National Institutes of Health Clinical Center, 9000 Rockville Pike
2277
mi
from 91732
Bethesda, MD
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated:  2/29/2016
Children's Hopsital of Los Angeles
15
mi
from 91732
Los Angeles, CA
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Children's Hopsital of Los Angeles
15
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated:  2/29/2016
University of California, San Diego
99
mi
from 91732
San Diego, CA
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
University of California, San Diego
99
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated:  2/29/2016
Childrens National Medical Center
2281
mi
from 91732
Washington,
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Childrens National Medical Center
2281
mi
from 91732
Washington,
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated:  2/29/2016
Children'S Diagnostic Treatment Center
2316
mi
from 91732
Fort Lauderdale, FL
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Children'S Diagnostic Treatment Center
2316
mi
from 91732
Fort Lauderdale, FL
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated:  2/29/2016
University of Miami
2320
mi
from 91732
Miami, FL
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
University of Miami
2320
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated:  2/29/2016
University of South Florida
2135
mi
from 91732
Tampa, FL
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
University of South Florida
2135
mi
from 91732
Tampa, FL
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated:  2/29/2016
Stoger Hospital of Cook County
1729
mi
from 91732
Chicago, IL
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Stoger Hospital of Cook County
1729
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated:  2/29/2016
Tulane University
1655
mi
from 91732
New Orleans, LA
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Tulane University
1655
mi
from 91732
New Orleans, LA
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated:  2/29/2016
Montefiore Medical Center
2438
mi
from 91732
Bronx, NY
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Montefiore Medical Center
2438
mi
from 91732
Bronx, NY
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated:  2/29/2016
Mt. Sinai Hospital
2432
mi
from 91732
New York City, NY
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Mt. Sinai Hospital
2432
mi
from 91732
New York City, NY
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated:  2/29/2016
Children's Hospital of Philadelphia
2375
mi
from 91732
Philadelphia, PA
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Children's Hospital of Philadelphia
2375
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
Identification of Celiac Ganglia
Identification of Celiac Ganglia for Endoscopic Ultrasound
Status: Enrolling
Updated:  2/29/2016
Indiana University
1791
mi
from 91732
Indianapolis, IN
Identification of Celiac Ganglia
Identification of Celiac Ganglia for Endoscopic Ultrasound
Status: Enrolling
Updated: 2/29/2016
Indiana University
1791
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
Progressive Weight Loss and Metabolic Health
Progressive Weight Loss and Metabolic Health
Status: Enrolling
Updated:  3/1/2016
Washington University School of Medicine
1569
mi
from 91732
Saint Louis, MO
Progressive Weight Loss and Metabolic Health
Progressive Weight Loss and Metabolic Health
Status: Enrolling
Updated: 3/1/2016
Washington University School of Medicine
1569
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
Ghrelin and Insulin Resistance
Role of Ghrelin in the Improvement of Insulin Resistance After Roux-en-Y Gastric Bypass Surgery
Status: Enrolling
Updated:  3/2/2016
Vanderbilt University Medical Center
1762
mi
from 91732
Nashville, TN
Ghrelin and Insulin Resistance
Role of Ghrelin in the Improvement of Insulin Resistance After Roux-en-Y Gastric Bypass Surgery
Status: Enrolling
Updated: 3/2/2016
Vanderbilt University Medical Center
1762
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 13102
14
mi
from 91732
Artesia, CA
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 13102
14
mi
from 91732
Artesia, CA
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 15
25
mi
from 91732
Fountain Valley, CA
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 15
25
mi
from 91732
Fountain Valley, CA
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 13165
16
mi
from 91732
Lakewood, CA
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 13165
16
mi
from 91732
Lakewood, CA
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 10133
817
mi
from 91732
Denver, CO
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 10133
817
mi
from 91732
Denver, CO
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 25
2345
mi
from 91732
Newark, DE
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 25
2345
mi
from 91732
Newark, DE
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 12535
2318
mi
from 91732
Hollywood, FL
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 12535
2318
mi
from 91732
Hollywood, FL
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 12336
2314
mi
from 91732
Homestead, FL
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 12336
2314
mi
from 91732
Homestead, FL
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 10247
2311
mi
from 91732
Miami Lakes, FL
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 10247
2311
mi
from 91732
Miami Lakes, FL
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 1345
2320
mi
from 91732
Miami, FL
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 1345
2320
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 1345
2320
mi
from 91732
Miami, FL
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 1345
2320
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 1345
2320
mi
from 91732
Miami, FL
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 1345
2320
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 1345
2320
mi
from 91732
Miami, FL
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 1345
2320
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 1345
2320
mi
from 91732
Miami, FL
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 1345
2320
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site ZEIG
2308
mi
from 91732
Pembroke Pines, FL
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site ZEIG
2308
mi
from 91732
Pembroke Pines, FL
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 13121
2304
mi
from 91732
West Palm Beach, FL
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 13121
2304
mi
from 91732
West Palm Beach, FL
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 11
1966
mi
from 91732
Detroit, MI
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 11
1966
mi
from 91732
Detroit, MI
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 11136
218
mi
from 91732
Henderson, NV
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 11136
218
mi
from 91732
Henderson, NV
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 60
217
mi
from 91732
Las Vegas, NV
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 60
217
mi
from 91732
Las Vegas, NV
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 10187
2436
mi
from 91732
Brooklyn, NY
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 10187
2436
mi
from 91732
Brooklyn, NY
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 1355
2432
mi
from 91732
New York, NY
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 1355
2432
mi
from 91732
New York, NY
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 1355
2432
mi
from 91732
New York, NY
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 1355
2432
mi
from 91732
New York, NY
Click here to add this to my saved trials